Quick Summary
Brooklime (Veronica beccabunga) is a plant species traditionally referenced for various uses. However, current high-quality clinical human studies on its efficacy or safety are lacking. Recent scientific literature contains no documented human clinical trials, systematic reviews, or meta-analyses specifically addressing its therapeutic benefits or adverse effects.
What is it
Brooklime, scientifically known as Veronica beccabunga, is a perennial aquatic plant commonly found near streams and rivers. It is recognized for its small, succulent leaves and blue flowers. The plant belongs to the plantain family (Plantaginaceae) and has been botanically and phytochemically characterized in several studies.
Traditional Uses
Historical and folk references cite brooklime for various traditional applications, which may include external uses and general health-related purposes. However, these traditional uses are primarily documented in botanical and ethnobotanical literature and lack verification through rigorous clinical research.
Active Compounds
Phytochemical investigations have identified compounds such as phenylethanoid triglycosides in Veronica beccabunga. These constituents have been characterized chemically, but their biological effects in humans remain unestablished due to limited evidence.
Potential Benefits with Evidence Levels
- Insufficient Evidence:
- No randomized controlled trials, clinical trials, systematic reviews, or meta-analyses evaluating human clinical effects of Veronica beccabunga were found.
- Available literature mainly covers botanical, taxonomical, or phytochemical aspects without validating health claims in humans.
Side Effects
There are no specific adverse effects related to brooklime consumption or use reported in the available research data. Due to the absence of clinical safety studies in humans, comprehensive side effect profiles have not been established.
Drug Interactions
No evidence or reports detailing drug interactions involving Veronica beccabunga were identified in the reviewed data.
Who Should Avoid It
No documented contraindications or warnings based on clinical evidence are currently available for brooklime. However, due to lack of safety data, caution is advised. There is no clinical safety information regarding its use during pregnancy or breastfeeding, so use by pregnant or breastfeeding individuals is not recommended without medical supervision.
Evidence Limitations
- Lack of human clinical research evaluating medicinal benefits or risks of Veronica beccabunga.
- Most studies focus on botanical, ecological, or animal-related research rather than direct human health outcomes.
- No controlled clinical trials or meta-analyses support evidence-based medicinal use or safety.
- Traditional use references exist but are not substantiated by rigorous scientific data in humans.
References
- Veronica beccabunga Linn. Indian Medicinal Plants, 2007. Springer New York. DOI: 10.1007/978-0-387-70638-2_1730
- Veronica Beccabunga Extract, Springer Lexikon Kosmetik und Körperpflege, 2007. Springer Berlin Heidelberg. DOI: 10.1007/978-3-540-71095-0_11009
- Molecular and morphometric analysis of Veronica L. section Beccabunga (Hill) Dumort., Aquatic Botany, 2017. Elsevier BV. DOI: 10.1016/j.aquabot.2016.09.010
- A new phenylethanoid triglycoside in Veronica beccabunga L, Biochemical Systematics and Ecology, 2011. Elsevier BV. DOI: 10.1016/j.bse.2011.02.008
- Veronica beccabunga: Lansdown, R.V., IUCN Red List of Threatened Species, 2012. IUCN. DOI: 10.2305/iucn.uk.2013-1.rlts.t167923a13574152.en
Last Reviewed
June 2024
Informational Disclaimer
The information provided on this page is for educational purposes only and does not constitute medical advice. Brooklime (Veronica beccabunga) has limited scientific evidence regarding its health effects and safety in humans. Always consult a qualified healthcare professional before using any herb or supplement, especially if you are pregnant, breastfeeding, taking medication, or have a medical condition.